Jia, Yanlin
Chen, Ken
Lin, Peihui
Lieber, Gissela
Nishi, Miyuki
Yan, Rosalie
Wang, Zhen
Yao, Yonggang
Li, Yu
Whitson, Bryan A.
Duann, Pu
Li, Haichang
Zhou, Xinyu
Zhu, Hua
Takeshima, Hiroshi
Hunter, John C.
McLeod, Robbie L.
Weisleder, Noah
Zeng, Chunyu
Ma, Jianjie
Article History
Received: 25 February 2014
Accepted: 13 June 2014
First Online: 18 July 2014
Competing interests
: J.M. and N.W. have an equity interest in TRIM-edicine, which develops rhMG53 for treatment of human diseases. Patents on the use of MG53 are held by Rutgers University—Robert Wood Johnson Medical School